Novo Nordisk points to the companys role in directing how the medication is dispensed and used, including providing instructional materials, as evidence that Hims actively promoted the alleged infringement
Meyer, D.E
While practical challenges including cost, access, and manufacturing constraints currently limit the widespread adoption of tirzepatide, the clinical evidence suggests that dual agonism represents the future direction of metabolic therapy
Your medical team will track your progress, monitor for side effects, and make adjustments to your dosage or treatment length as needed
GLP-1 users may differ from nonusers in ways that are not fully captured, such as socioeconomic status, health behaviors, disease severity, medication adherence, or access to care." Lakkis notes that the study also did not report how much weight participants lost, making it difficult to determine how much of the benefit may have been driven by weight reduction itself
In this context, routine assessment of BC and functional parameters should become a clinical priority, shifting the focus from weight alone to the broader concept of quality weight loss
